Latest in News & Research
FDA Approves Botox Competitor That Lasts Longer
Daxxify lasts longer than Botox, with about 80 percent of users seeing no or mild facial lines at four months after injection
Early Postoperative Microneedling May Improve Surgical Scars
Daxxify lasts longer than Botox, with about 80 percent of users seeing no or mild facial lines at four months after injection
Patients With Alopecia Areata Prefer Shared Decision-Making
Reduced decisional regret seen in association with incorporation of shared decision-making by physicians
Two-Photon Fluorescence Microscopy Promising for Nonmelanoma Skin Cancer
TPFM has high sensitivity, specificity, accuracy for basal cell carcinoma, squamous cell carcinoma diagnosis
FDA Approves SPEVIGO for Generalized Pustular Psoriasis Flares
The monoclonal antibody infusion is approved for use in adults
Diagnosis of Psoriasis May Be Delayed in Primary Care
Medical records of psoriasis patients show reports of symptoms suggestive of psoriasis five years before diagnosis
Genetic Spectrum of Uncombable Hair Syndrome Described
Pathogenic variants discovered in
How Does Microneedling Compare to Chemical Peeling for Acne Scars?
Treatment efficacy superior for patients receiving microneedling versus 35 percent glycolic acid peels every two weeks
Study Aims to Identify Melanoma Patients With High-Risk Disease
Patients with AJCC IIIA and sentinel node metastatic tumor deposits ≥0.3 mm have lower five-year disease-specific survival rates
Tecovirimat Well Tolerated for Treatment of Monkeypox
By day 21, 23 of 25 patients had resolution of lesions and pain; none of the patients discontinued treatment
Is VTE Risk Increased With Atopic Dermatitis, JAK Inhibitor Use?
Systematic review, meta-analysis show no increased incidence of venous thromboembolism in patients with atopic dermatitis, treatment with JAK inhibitors
Features of Congenital Nail Matrix Nevi Similar to Adult Subungual Melanoma
Congenital and congenital-type nail matrix nevi predominantly display irregular pattern of longitudinal microlines
Sun Protection Low Among American Indians/Alaskan Natives
Lower hat use, sunscreen use reported, in addition to more frequent use of indoor tanning
Gradient-Boosted Decision Trees Predict Treatment Success for Psoriasis
Gradient-boosted decision trees perform better than logistic regression for predicting biologic therapy leading to treatment duration of at least three years
Guidance Developed for Use of Laser-Assisted Drug Delivery
Key findings that informed guidelines include that LADD is safe for adults, adolescents, immunosuppressed patients
Prior Diagnoses Influence Dermatopathologists' Interpretations
Prior diagnoses swayed dermatopathologists from correct diagnosis to incorrect diagnosis in the interpretation of melanocytic lesions
Comorbidities Up Among Patients With ESRD, Concomitant Psoriasis
Patients with end-stage renal disease and psoriasis are younger, more often obese, and more often have cancer, diabetes, CAD
Pregnancy Does Not Affect Survival in Women With Melanoma
Racial and socioeconomic factors linked to melanoma survival in women of childbearing age
Actinic Keratosis Diagnosed in Almost One-Third of Older Adults
Authors say increased use of topical fluorouracil may be warranted
Treatment Needs Often Unmet for Generalized Pustular Psoriasis
Patients with flares more likely to have inpatient, emergency department visits
Causal Link Suggested for Psoriasis, Cardiovascular Disease
Increased risks noted for heart failure, atrial fibrillation, myocardial infarction, valvular heart disease, large artery stroke
What Is the Long-Term Drug Survival of Dupilumab in Patients With Eczema?
Dupilumab demonstrates sufficient drug survival up to three years for treatment of atopic dermatitis
Hypericin Photodynamic Therapy Effective for Early-Stage MF/CTCL
Hypericin PDT more effective than placebo after six weeks of treatment; index lesion response rate increased with progressive cycles of treatment
24 of 1292